Endothelial Dysfunction clinical trials

Explore recruiting endothelial dysfunction clinical trials.

Recruiting endothelial dysfunction studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Endothelial Dysfunction trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Treatment of vascular stiffness in patients with autosomal dominant polycystic kidney disease

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

The effect of sertraline on anxiety-depressive symptoms, endothelial dysfunction and biomarkers in heart failure patients with preserved ejection fraction

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Statins to Prevent Immune checkpoint inhibitor-induced pRogression of AtheroscLerosis

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Inhibition of late sodium current (INa) to prevent coronary MICROvascular dysfunction in patients presenting with ST-Elevation myocardial infarction and multivessel disease: A multicenter, randomized, controlled and open label study (INaMICRON study)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy of simvastatin reducing liver fibrosis in patients with advanced fibrosis due to alcohol: a randomized, double-blind, placebo-controlled clinical trial.

Spain

Phase II and Phase III (Integrated) EU CTIS Study details

Randomized controlled trial evaluating the impact of mineralocorticoid receptor blockade by eplerenone on echocardiographic abnormalities among kidney graft recipient under calcineurin inhibitors. KT-CANOPY: Cardiac improvement by eplerenone among patients under cyclosporine or tacrolimus for kidney transplantation.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Endothelial Dysfunction trials by city

Endothelial Dysfunction in Toronto Endothelial Dysfunction in Vancouver Endothelial Dysfunction in Montreal Endothelial Dysfunction in Calgary Endothelial Dysfunction in Edmonton Endothelial Dysfunction in Ottawa Endothelial Dysfunction in Winnipeg Endothelial Dysfunction in Quebec City Endothelial Dysfunction in Hamilton Endothelial Dysfunction in Kitchener Endothelial Dysfunction in London Endothelial Dysfunction in Halifax Endothelial Dysfunction in New York Endothelial Dysfunction in Los Angeles Endothelial Dysfunction in Chicago Endothelial Dysfunction in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease